“ounger patients with low genomic risk breast cancer may reasonably consider de-escalated adjuvant therapy,” the researchers wrote.

USA: Researchers have found in a new study that adjuvant radiotherapy (RT) or endocrine therapy (ET) significantly reduces ...

A phase 2 trial tested the efficacy of local stereotactic body radiation therapy (SBRT) use after radical prostatectomy.

Claudine Isaacs, MD: For this patient who's progressed after more than 12 months with an ESR1 mutation and HER2-low disease ...

Sustained two-year treatment with tildrakizumab improved the psychological well-being of people with moderate to severe ...

Discover a study on focal therapy for prostate cancer, showing how the Decipher genomic score predicts treatment success and ...

A breakthrough technique uses a cell's genetic profile to predict abnormal breast cells and pinpoint which women may develop ...

Proton therapy did not outperform IMRT in quality-of-life outcomes for patients with oropharyngeal cancer. Both treatments achieved similarly strong control and survival, according to new trial ...

By Dennis Thompson HealthDay ReporterTHURSDAY, Oct. 2, 2025 (HealthDay News) — A genetic risk score can help predict which ...

Researchers said a genetic risk score can help predict invasive breast cancer risks for women after abnormal cells have been found in their breast tissue.

A genetic risk score could one day help women with DCIS or LCIS know if they are high or low risk and decide which treatment ...